Tumor site Treatment MSTS 2 weeks 4 weeks Upper Limb 1humerus Silicate granules 58% 74%   1 humerus Silicate granules+BMMCs 81% 90% 1 humerus Silicate granules+BMMCs 78% 88% Lower Limb 1   knees Silicate granules 59% 72% 11 Femur Silicate granules 62% 75% 1   Femur Silicate granules+BMMCs 72% 76% 3   Tibia Silicate granules 51% 65% 1   Tibia Silicate granules+BMMCs 85% 92%

Table 3: Musculoskeletal tumour society functional outcome score (msts) into upper and lower limb.